Publication | Closed Access

Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib

Tumor ResponseMedicineCancer ManagementPathologyCancer TreatmentOncologyRadiation OncologyRisk FactorsLung CancerHealth Sciences